NCT00362921View on ClinicalTrials.gov

Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme

PHASE2CompletedINTERVENTIONAL

Enrollment

52

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

July 31, 2008

Conditions

Recurrent Adult Brain Tumor

Interventions

DRUG

Gliadel wafers in combination with O6-benzylguanine

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER